Murine CD19+ B-ALL cells are typically less susceptible to CAR T cell–mediated killing in vitro due to the rapid endocytosis of the target antigen; thus, hCD19+ PDAC cells were included as an additional experimental condition (66). Here, CD19 is linked to acute lymphoblastic leukemia.